Clinical evaluation of germline polymorphisms associated with capecitabine toxicity in breast cancer: TBCRC-015
Year: 2020
Type: article
Authors: Peter H. O’Donnell, Vassily Trubetskoy, Ashley Nurhussein-Patterson, Julianne P. Hall, Aritro Nath, Dezheng Huo, Gini F. Fleming, James N. Ingle, Vandana G. Abramson, P. K. Morrow, Anna Maria Storniolo, Andres Forero, Catherine Van Poznak, Minetta C. Liu, Jenny C. Chang, Douglas E. Merkel, Jeffrey M. Peppercorn, Hope S. Rugo, E. Claire Dees, Olwen M. Hahn, Philip C. Hoffman, Gary L. Rosner, R. Stephanie Huang, Mark J. Ratain, Nancy Cox, Olufunmilayo I. Olopade, Antonio C. Wolff, M. Eileen Dolan, Rita Nanda
Institutions: University of Chicago, Charité - Universitätsmedizin Berlin, Mayo Clinic, Vanderbilt University, Amgen (United States), The University of Texas MD Anderson Cancer Center, Indiana University Bloomington, University of Alabama at Birmingham, University of Michigan, Georgetown University, Baylor College of Medicine, Endeavor Health, Duke University, Massachusetts General Hospital, University of California, San Francisco, University of North Carolina at Chapel Hill, Johns Hopkins University, University of Minnesota
Language: English
Subfield: Pharmacology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W3021899016